The stock of Aurora Cannabis Inc (ACB) has seen a -1.64% decrease in the past week, with a 0.50% gain in the past month, and a -7.17% decrease in the past quarter. The volatility ratio for the week is 5.18%, and the volatility levels for the past 30 days are at 7.29% for ACB. The simple moving average for the past 20 days is 1.51% for ACB’s stock, with a -25.23% simple moving average for the past 200 days.

Is It Worth Investing in Aurora Cannabis Inc (NASDAQ: ACB) Right Now?

Aurora Cannabis Inc (NASDAQ: ACB) has a higher price-to-earnings ratio of 0.58x compared to its average ratio. compared to its average ratio and a 36-month beta value of 2.44. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 8 as “hold,” and 0 as “sell.”

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"


The average price point forecasted by analysts for Aurora Cannabis Inc (ACB) is $0.68, which is $0.22 above the current market price. The public float for ACB is 433.52M, and currently, short sellers hold a 9.04% ratio of that float. The average trading volume of ACB on November 20, 2023 was 21.52M shares.

ACB) stock’s latest price update

Aurora Cannabis Inc (NASDAQ: ACB) has seen a decline in its stock price by -0.58 in relation to its previous close of 0.47. However, the company has experienced a -1.64% decline in its stock price over the last five trading sessions. InvestorPlace reported 2023-11-16 that By most accounts, Canada’s experiment with legalizing cannabis has been a complete failure. Five years after the recreational drug was legalized on a national level, most cannabis producers remain deeply unprofitable, struggling to survive, seeing their share prices plunge by more than 90%.

ACB Trading at -19.80% from the 50-Day Moving Average

After a stumble in the market that brought ACB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.76% of loss for the given period.

Volatility was left at 7.29%, however, over the last 30 days, the volatility rate increased by 5.18%, as shares surge +3.61% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.61% lower at present.

During the last 5 trading sessions, ACB fell by -1.64%, which changed the moving average for the period of 200-days by -59.09% in comparison to the 20-day moving average, which settled at $0.4562. In addition, Aurora Cannabis Inc saw -49.89% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for ACB

Current profitability levels for the company are sitting at:

The net margin for Aurora Cannabis Inc stands at -113.73. The total capital return value is set at -15.99, while invested capital returns managed to touch -17.91. Equity return is now at value 73.45, with 39.21 for asset returns.

Based on Aurora Cannabis Inc (ACB), the company’s capital structure generated 46.81 points at debt to equity in total, while total debt to capital is 31.88. Total debt to assets is 24.56, with long-term debt to equity ratio resting at 16.45. Finally, the long-term debt to capital ratio is 11.21.

When we switch over and look at the enterprise to sales, we see a ratio of 0.77, with the company’s debt to enterprise value settled at 0.87. The receivables turnover for the company is 4.78 and the total asset turnover is 0.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.98.


To put it simply, Aurora Cannabis Inc (ACB) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.